Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high- risk HIV-negative women

被引:216
|
作者
Palefsky, JM
Holly, EA
Ralston, ML
Da Costa, M
Greenblatt, RM
机构
[1] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
来源
JOURNAL OF INFECTIOUS DISEASES | 2001年 / 183卷 / 03期
关键词
D O I
10.1086/318071
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Little is known about the epidemiology of anal human papillomavirus (HPV) infection in women. We studied 251 human immunodeficiency virus (HIV)-positive and 68 HIV-negative women for the presence of anal HPV by use of polymerase chain reaction (PCR) and hybrid capture. Medical and behavioral risk factors were evaluated; 76% of HIV-positive and 42% of HIV-negative women were found to have anal HPV DNA via analysis by PCR (relative risk [RR], 1.8; 95% confidence interval [CI], 1.3-2.5). Among 200 women for whom there were concurrent anal and cervical HPV data, anal HPV was more common than cervical HPV in both HIV-positive (79% vs. 53%) and HIV-negative women (43% vs. 24%). By multivariate analysis of HIV-positive women, CD4(+) cell counts less than or equal to 200 cells/mm(3), compared with counts >500 cells/mm(3) (RR, 1.4; 95% CI, 1.1-1.5), and cervical HPV infection (RR, 1.3; 95% CI, 1.1-1.4) were associated with anal HPV infection. Women >45 years old had reduced risk, compared with women <36 years old (RR, 0.80; 95% CI, 0.50-0.99), as did African American women (RR, 0.86; 95% CI, 0.72-1.0), compared with white women. Anal HPV infection is underrecognized in HIV-positive and high-risk HIV-negative women.
引用
收藏
页码:383 / 391
页数:9
相关论文
共 50 条
  • [1] Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men
    Palefsky, JM
    Holly, EA
    Ralston, ML
    Jay, N
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (02): : 361 - 367
  • [2] Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women
    Palefsky, JM
    Minkoff, H
    Kalish, LA
    Levine, A
    Sacks, HS
    Garcia, P
    Young, M
    Melnick, S
    Miotti, P
    Burk, R
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (03) : 226 - 236
  • [3] Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women
    Silverberg, MJ
    Schneider, MF
    Silver, B
    Anastos, KM
    Burk, RD
    Minkoff, H
    Palefsky, J
    Levine, AM
    Viscidi, RP
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (04) : 511 - 519
  • [4] Cervicovaginal human papillomavirus infection in HIV-positive and high risk HIV-negative women
    Palefsky, J
    Minkoff, H
    Kalish, LA
    Levine, A
    Sacks, H
    Garcia, P
    Young, M
    Melnick, S
    Miotti, P
    Burk, R
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (04): : SA3 - SA3
  • [5] Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection
    Cu-Uvin, S
    Ko, HJ
    Jamieson, DJ
    Hogan, JW
    Schuman, P
    Anderson, J
    Klein, RS
    [J]. CLINICAL INFECTIOUS DISEASES, 2002, 34 (10) : 1406 - 1411
  • [6] Prevalence of Anal Intraepithelial Neoplasia with Respect to High Risk Human Papillomavirus and Human Immunodeficiency Virus (HIV) Infection
    Russell, Donna K.
    Warner, Julieann N.
    Giampoli, Ellen J.
    Bonfiglio, Thomas A.
    Hoda, Rana S.
    [J]. CANCER CYTOPATHOLOGY, 2008, 114 (05): : 398 - 398
  • [7] RISK-FACTORS FOR ANAL HUMAN PAPILLOMAVIRUS INFECTION AND ANAL CYTOLOGIC ABNORMALITIES IN HIV-POSITIVE AND HIV-NEGATIVE HOMOSEXUAL MEN
    PALEFSKY, JM
    SHIBOSKI, S
    MOSS, A
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1994, 7 (06): : 599 - 606
  • [8] Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women
    Ahdieh, L
    Klein, RS
    Burk, R
    Cu-Uvin, S
    Schuman, P
    Duerr, A
    Safaeian, M
    Astemborski, J
    Daniel, R
    Shah, K
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (06): : 682 - 690
  • [9] Anal and penile high-risk human papillomavirus prevalence in HIV-negative and HIV-infected MSM
    van Aar, Fleur
    Mooij, Sofie H.
    van der Sande, Marianne A. B.
    Speksnijder, Arjen G. C. L.
    Stolte, Ineke G.
    Meijer, Chris J. L. M.
    Verhagen, Dominique W. M.
    King, Audrey J.
    de Vries, Henry J. C.
    van der Loeff, Maarten F. Schim
    [J]. AIDS, 2013, 27 (18) : 2921 - 2931
  • [10] The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda
    Veldhuijzen, Nienke J.
    Braunstein, Sarah L.
    Vyankandondera, Joseph
    Ingabire, Chantal
    Ntirushwa, Justin
    Kestelyn, Evelyne
    Tuijn, Coosje
    Wit, Ferdinand W.
    Umutoni, Aline
    Uwineza, Mireille
    Crucitti, Tania
    van de Wijgert, Janneke H. H. M.
    [J]. BMC INFECTIOUS DISEASES, 2011, 11